EMPAGLIFLOZIN
Clinical Indication
Chronic heart failure with reduced ejection fraction.
Comments
In line with NICE TA773
Date of classification
May 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .